Fig. 2From: Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin–angiotensin–aldosterone system (RAAS) inhibitors: a systematic reviewFlowchart showing steps in the qualitative synthesis of evidence from literatureBack to article page